Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes
The DOI matches its Crossref record.
Abstract
Anthralin is one of the most effective and safest therapeutic agents for the treatment of psoriasis, a skin disease characterized by epidermal hyperproliferation and hyperkeratosis. The drug induces and inflammatory response in the skin involving the expression of cytokine and cell adhesion molecule genes that is thought to be essential for its therapeutic efficacy. Reactive oxygen intermediates (ROIs) generated in vivo during the auto-oxidation of anthralin were discussed as mediators of the inflammatory response, but it is not yet understood how this is translated into novel inflammatory gene expression. In this study, we show that at little as 10 microM anthralin can activate a prototypic form of transcription factor NF-(kappa)B, a central transcriptional regulator of inflammatory and immune responses. Two different lines of evidence show that ROIs, in particular H2O2, are second messengers for the anthralin-induced NF-(kappa)B activation. Firstly, the activation could be inhibited by the structurally unrelated antioxidants N-acetyl-L-cysteine and pyrrolidinedithiocarbamate. Secondly, keratinocytes stably overexpressing catalase showed a significant reduction of NF-(kappa)B activation, while stable overexpression of Cu/Zn-superoxide dismutase augmented the anthralin effect. Our data suggest that ROI-induced NF-(kappa)B plays a role in the anti-psoriatic activity of the drug anthralin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Oxidative stress and nuclear factor-κB activation
Bowie, A., & O’Neill, L. A. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00296-8 · Cited by 858
Seitz, C. S., Lin, Q., Deng, H., & Khavari, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2307 · Cited by 436
Jiaravuthisan, M. M., Sasseville, D., Vender, R. B., Murphy, F., & Muhn, C. Y. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.07.073 · Cited by 416
NF-κB as a therapeutic target in chronic inflammation: recent advances
Makarov, S. S. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01814-1 · Cited by 379
NF-κB: An essential transcription factor in psoriasis
Goldminz, A. M., Au, S. C., Kim, N., Gottlieb, A. B., & Lizzul, P. F. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.11.002 · Cited by 364
What is a role of haeme oxygenase‐1 in psoriasis? Current concepts of pathogenesis
Wojas‐Pelc, A., & Marcinkiewicz, J. (2007) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2006.00505.x · Cited by 36
“ROS-induced NF-(kappa)B induces severe skin inflammation that is thought to be essential for the drug anthralin therapeutic efficacy (Schmidt et al. 1996).”
Background
Metadata
- Authors
- Schmidt, K. N., Podda, M., Packer, L., & Baeuerle, P. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-06-01
- Volume
- 156
- Issue
- 11
- Pages
- 4514-4519
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1598869478
- Cited by
- 57
- References
- 0
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.